Skip to main content
. 2022 Oct 7;22(4):289–300. doi: 10.1007/s40268-022-00404-4
The covariates propofol pharmacokinetic model showed an acceptable level of performance for use in target-controlled infusions of propofol in adult clinical practice.
The covariates model performed non-inferiorly when compared to other published pharmacokinetic models for propofol target-controlled infusions.